Xilio Therapeutics, Inc. (XLO) Earnings
|
Expand Research on XLO
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -68.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -1.2% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/6/26  |
Q425 | N/A | -$0.07 | N/A | N/A | $10.9M | N/A | N/A | N/A | ||
| 3/4/26 |
Q425 | N/A | -$0.07 | N/A | N/A | $10.9M | N/A | N/A | N/A | ||
| 11/13/25 | Q325 | -$0.11 | -$0.05 | -$0.06 | $19.07M | $16.48M | N/A |  | | Details | |
| 11/12/25 |
Q325 | N/A | -$0.05 | N/A | N/A | $16.48M | N/A | N/A | N/A | ||
| 11/11/25 |
Q325 | N/A | -$0.05 | N/A | N/A | $16.48M | N/A | N/A | N/A | ||
| 11/10/25 |
Q325 | N/A | -$0.05 | N/A | N/A | $16.48M | N/A | N/A | N/A | ||
| 11/7/25 |
Q325 | N/A | -$0.05 | N/A | N/A | $16.48M | N/A | N/A | N/A | ||
| 11/6/25 |
Q325 | N/A | -$0.05 | N/A | N/A | $16.48M | N/A | N/A | N/A |
